Cardinal Health, Inc. (BMV:CAH)
2,973.09
0.00 (0.00%)
At close: May 28, 2025, 2:00 PM CST
Revenue by Product
Fiscal year is July - June.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2013 - 2020 |
Pharmaceutical and Specialty Solutions | 204.88B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical and Specialty Solutions Growth | 0.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Global Medical Products and Distribution | 12.55B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Global Medical Products and Distribution Growth | 1.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment | 4.95B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment Growth | 13.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Segment | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Segment Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Segment | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Segment Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Distribution and Specialty Solutions | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Distribution and Specialty Solutions Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nuclear and Precision Health Solutions | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nuclear and Precision Health Solutions Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Distribution and Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Distribution and Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardinal Health at-Home Solutions | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardinal Health at-Home Solutions Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is July - June.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2013 - 2020 |
Pharmaceutical and Specialty Solutions Segment Profit | 2.21B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical and Specialty Solutions Segment Profit Growth | 11.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Global Medical Products and Distribution Segment Profit | 112.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Global Medical Products and Distribution Segment Profit Growth | 115.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment Segment Profit | 467.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment Segment Profit Growth | 13.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Profit | -541.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Profit Growth | -63.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Segment Profit | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Segment Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Segment Profit | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Segment Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is July - June.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2013 - 2020 |
United States | 222.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 0.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International | -716.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Growth | 24.52% |
Log In |
Log In |
Log In |
Log In | Upgrade
|